Unlock the future of training at our upcoming webinar, showcasing innovative student projects from The University of Melbourne's Master of Biotechnology program. In collaboration with SeerPharma, the students have explored the application of emerging technologies like Augmented Reality (AR), immersive 360-degree video, and chatbot assessments to...
Artificial Intelligence (AI) and emerging technologies are rapidly advancing, influencing every aspect of business operations, including the biotechnology and life sciences sectors.
A decade ago, Duke-NUS Medical School established the Centre of Regulatory Excellence (CoRE) to enhance health products regulatory systems and competency across ASEAN and the broader Asia-Pacific region. CoRE is pivotal in supporting policy innovation and facilitating progress towards effective and efficient health products regulation. As a...
SeerPharma consults on 100 to 150 projects every year. Many of these engagements with pharmaceutical and medical device companies involve providing ongoing support for business needs related to Quality Assurance (QA) and Good Manufacturing Practice (GMP) compliance. Our clients continue to rely on our expertise for regular remote and on-site...
INFOGRAPHIC: A snapshot of how SeerPharma supported its clients with Quality and GMP Best-Practices in 2023 through QA & GMP Consulting, Auditing, Training and MasterControl "Qx" electronic Quality Management Systems (eQMS) & "Mx" Manufacturing Execution Systems (MES) with electronic Batch Records (eBR).
INFOGRAPHIC: A snapshot of how SeerPharma supported its customers with Quality and GMP Best-Practices in 2022.
INFOGRAPHIC: A snapshot of how SeerPharma supported its customers with Quality and GMP Best-Practices in 2021.
Research and operations of Medical Technology, Biotechnology and Pharmaceutical (MTP) companies aligned with and in some cases certified to Quality Management System (QMS) Standards will ensure Australia is at the forefront of medical innovation.
In a previous article we looked at the emergence of MTP 4.0 (Industry 4.0 for the Medical Technology, Biotechnology and Pharmaceutical sector) as a holistic operating model to facilitate an agile development and manufacturing environment for the near future.
Being holistic, the operating model covers all aspects of the business, using a digital...
MTPConnect is a not-for-profit organisation, established by the Australian Federal Government’s Industry Growth Initiative. MTPConnect’s aim is to accelerate the rate of growth of the medical technologies, biotechnologies and pharmaceuticals (MTP) sector to increase commercialisation, collaboration and establish Australia as an Asia-Pacific hub...
Copyright © SeerPharma
